Isansys Lifecare is proud to announce it has been shortlisted in the Most Transformative Digital Healthcare Company category at the OBN Annual Awards 2019. The award recognises the significant uptake of the technology by healthcare providers and the real impact Isansys' technology is having on patients and hospitals globally. 
Initial results from a feasibility study conducted by Eli Lilly and Company (NYSE: LLY), Evidation Health, and Apple Inc. (NASDAQ: AAPL) showed that an iPhone, Apple Watch, iPad and the Beddit sleep monitoring device, in combination with digital apps may be able to differentiate people with mild cognitive impairment (MCI) and mild Alzheimer's disease dementia. 
IMS MAXIMS has secured a place on a framework contract established by NHS England to make it easier for healthcare economies to buy the IT they need for transformation and integration projects.
The company has secured a place on lot one of the Health Systems Support Framework, which covers electronic patient records for acute and mental health trusts.
One of the first pathology networks in the country, set up to serve more than two million people in south west London, has signed a contract with CliniSys for a new laboratory information management system (LIMS). South West London Pathology, which was established in 2014, is now working with the company to prepare to deploy WinPath Enterprise. 
MedTech Europe released today a call to action towards digital health interoperability, endorsing the European Commission's Electronic Health Record Exchange Format released on 6 February 2019. The statement also called on European national and regional health authorities, payers and procurers, and adjacent industries, to do the same. 
Oxford Health NHS Foundation Trust has introduced a new observation protocol for checking the safety of patients with severe mental health conditions at night, after a formal evaluation of technology from Oxehealth. 
QUIBIM is helping to advance knowledge of the most lethal pediatric tumors through EU-funded project PRIMAGE, which exploits precision information from medical imaging to establish tumor prognosis, and expected treatment response using radiomics, imaging biomarkers and artificial intelligence (AI).